“一直在等待基本药物目录颁布，这关系着明年企业的发展方向，可快年底了一直没消息。”一家药企副总告诉《经济参考报》记者。

"Have been waiting for essential drugs list issued,This relation is worn next enterprise development direction,Quickly the end of the year has been no news."A medicine enterprises assistant chief told[Economic reference to]reporter.

　　2009年8月，卫生部颁布了《国家基本药物目录》(包括化药、中成药共307个药品品种)，这标志着我国开始启动了基本药物制度。按照相关规定，基本药物目录每三年调整一次，新目录本应今年问世。可2012版基本药物目录至今尚未出台。业内人士指出，迟迟未出台的原因是基本药物制度涉及多方利益，而基本药物目录需要增补内容较多。

In August 2009,The ministry of health has issued a[The national essential drug list](Including chemical drug/Traditional Chinese medicine is a total of 307 drug varieties),This symbolized our country launched essential drugs system.According to the relevant provisions,Essential drugs list every three years adjust a,The new catalogue should be the advent of this year.Can 2012 version of essential drugs list have not yet come.The personage inside course of study points out that,Didn't publicized reason is essential drugs system involves many interests,And the essential drugs list need to supplement more content.

　　基本药物是世界卫生组织于上世纪70年代提出的概念，是最重要的、基本的、不可缺少的、满足人民所必需的药品。目前全球已有160多个国家制定了本国的《基本药物目录》，其中105个国家制定和颁布了国家基本药物政策。

Essential drugs is the world health organization is put forward in the 1970 s concept,Is the most important/basic/indispensable/To meet the people's necessary drugs.The world more than 160 countries have established their own[Essential drugs list],The 105 countries have enacted and promulgated the national essential medicine policy.

　　我国国家基本药物制度是指对基本药物的遴选、生产、流通、使用、定价、报销、监测评价等环节实施有效管理的制度，并与公共卫生、基本医疗服务、基本医疗保障体系相衔接。

China's national essential drugs system refers to the basic drug selection/production/circulation/use/pricing/Submit an expense account/Monitoring and evaluation links such as implementing effective management system,And with the public health/Basic medical service/The basic medical security system connected.

　　“国家出台基本药物制度的初衷很好，但这一制度上场比较仓促，导致很多方面问题不清楚。”一位业内人士告诉记者，基本药物目录所包含品种全由专家提议，无须企业上报和参与。但每一品种背后都涉及不少企业的利益，因此“上某一品种、下某一品种”很难取舍。

"The country has issued essential drugs system of the original intention is very good,But this system is quite hasty play,Cause a lot of problems not clear."A personage inside course of study tells a reporter,Essential drugs list contains all varieties by expert proposal,Do not need to enterprise report and participation.But each species involved a lot behind the interests of the enterprise,therefore"A variety/Under a variety"It is difficult to choose.

　　记者了解到，业界反映目前基本药物制度运行中存在三大问题。

The reporter understands,The industry reflect the current essential drugs system existing in the operation three problems.

　　一是“唯低价中标”的原则，导致不少企业弃标。“基本药物招投标中，福建省的中标价格太低了。为了保护产品价格，我们只好放弃福建市场。”康缘药业沈经理告诉记者。

One is"Only low quoted price"principle,Lead to many enterprises abandon scale."Essential drugs for the bidding process,The fujian province won the bid price is too low.In order to protect the price of a product,We had to give up fujian market."Kang edge pharmaceutical shen manager told reporters.

　　云河药业股份有限公司总经理胡松谋以60片一瓶的复方丹参片为例说，由于三七药材的涨价，生产成本达到5 .6元一瓶；加上销售费用，投标价格应在6 .6元以上才是真实和合理的。但有的企业生产的60片一瓶的复方丹参片投标价格仅为2 .8元一瓶。“按照这一价格，我们根本生产不了该产品，只有弃标。”他说。

Cloud river pharmaceutical co., LTD. HuSongMou general manager with 60 piece of compound salvia miltiorrhiza tablet, for example said,Because sanqi (panax notoginseng) medicinal materials rise in price,The cost of production to achieve 5. 6 yuan a bottle;Plus sales expenses,Bid price should be in 6. 6 yuan of above is true and reasonable.But some enterprise production 60 piece of compound salvia miltiorrhiza tablet bid price is only 2. 8 yuan a bottle."According to the price,We simply cannot be produced the product,Only abandon scale."He said.

　　“有时，企业很为难。像围城里的人———拼命想进、一旦进了又想退出。”中国医药企业管理协会会长于明德说，基本药物目录让一些企业很尴尬。

"sometimes,Enterprise is very difficult.Like the people in the city - desperately want to get into/Once into the and want to quit."Chinese medicine enterprise management association YuMingDe said,Essential drugs list for some enterprise very embarrassed.

　　尴尬的原因是对有独家品种的企业，其品种进入基本药物目录后，该独家产品的价格有保证，企业生产积极性很高，愿意进入目录。但非独家品种进入基本药物目录，品牌等方面没有任何优势，只能在价格竞争战中拼 杀 。 “ 这 是 做 企 业 最 不 愿 见 到的。”于明德说。

Awkward reason is to have an exclusive varieties of enterprise,The varieties into basic drugs after directory,The exclusive product price is guarantee,Enterprise production enthusiasm high,Willing to enter the directory.But not exclusive variety into the essential drugs list,Without any advantage brand, etc,Only in price competition battle spell kill . " This is do enterprises industry most is not willing to see to."YuMingDe said.

　　一位权威人士指出，当前各地基本药物招标采购中“低价者中标”现象较普遍，药品质量等专业指标在中标过程中所占权重不足，评判标准不够客观，不能够充分体现企业产品质量因素，导致企业间在价格上激烈竞争，使规范经营、诚实守信的企业基本药物生产积极性不高，逐渐退出基本药物生产市场，这给药品质量安全带来新的风险。

An authoritative personage points out,The current basic drugs all bidding procurement"Low price is the"Phenomenon is very common,The quality of drugs and other professional index in the process of lack of weighting,Evaluation standard is not objective,Don't be able to be reflected adequately enterprise product quality factors,In enterprise in the fierce competition between the price,Make regulating the business/Honest and trustworthy enterprise basic drug production enthusiasm is not high,Gradually exit basic drug production market,This gives the drug quality safety brings new risks.

　　二是基本药物生产成本与中标价格存在“倒挂”现象。

The second is the basic drug production cost and the bid price exists"fuchsia"phenomenon.

　　权威人士指出，由于中药材等材料价格持续上涨等因素，药品生产成本、管理成本和质量控制成本也相应提高。但由于药品价格受到严格控制，而各地基本药物招标普遍采用最低价者中标的政策，导致生产成本与中标价格“倒挂”，这成为当前基本药物生产企业反映最为强烈的问题。

Authorities say,Due to the Chinese herbal medicine material such as the continuing rise in price factors,Pharmaceutical production cost/The management cost and quality control cost also increase.But because the price of drugs strictly controlled,And the basic drugs widely used all over the tender price is the policy,Lead to the production cost and the bid price"fuchsia",This become the essential drugs production enterprise reflects the most strong problem.

　　三是厂家和配送企业没有积极性，基本药物经常断货。

The third is manufacturer and distribution enterprise without enthusiasm,Essential drugs often break goods.

　　一位基层卫生院的院长反映，实施基本药物制度后，药品经常出现断货的局面“主要是部分药品的价格太低了，配送商没有积极性。”他说。

A grassroots the hospital dean reflect,After the implementation of essential drugs system,Drug often appear goods-stopping situation"Mainly is the partial drug price is too low,Distribution business without enthusiasm."He said.

　　深圳市海王银河医药投资有限公司运管总监王志宏说，基本药物价格低、需求量不大，而配送地区都在县乡村、配送成本较高，很多企业都不愿配送基本药物。

Shenzhen sea galaxy medical investment co., LTD. Pipe director WangZhiHong said,Essential drugs price low/Demand not,And distribution areas in the county rural/Distribution cost is higher,Many companies do not want to distribution essential drugs.

　　此外，地方保护主义也影响着基本药物的配送。“已中标的药品，本可通过省级医药公司或实力较强的医药公司直接配送到基层医疗卫生机构使用。可有的地方保护主义严重，硬性规定要把中标药品交由当地的医药公司配送。”

In addition,Local protectionism also affect basic drug distribution."Already the drug,This can be through the provincial pharmaceutical company or the stronger medicine company direct distribution to the basic medical and health agencies use.But some local protectionism serious,Hard and fast rules to put the drug to a local pharmaceutical companies distribution."

　　胡松谋指出，这些公司经营规模和实力差，一方面收取高额的配送费加重企业负担；另一方面，因配送能力差，不能保证及时配送和回款，不仅增加了生产企业的经济负担，还影响了基层医疗机构及时用药。

HuSongMou pointed out that,These companies operating scale and strength difference,On the one hand charge high distribution fee increase enterprise burden;On the other hand,For distribution ability is poor,Can't ensure timely delivery and collection,Not only increased production enterprise's economic burden,Also affects the grassroots medical institutions medicine in time.

　　“如同医保目录一样，基本药物目录涉及数千家企业的利益和医疗机构的使用。调整品种、调整制度可能是新版基本药物目录需要承载的难题。”记者从消息灵通人士处了解到，政策制定者已经意识到保证基本药物质量的重要性，“唯低价中标”将有所调整；而对“医保目录能否与基本药物目录合二为一”的呼声并未采纳。 □记者　曾亮亮　实习生　姜韩 北京报道

"As health care as directory,Essential drugs list involves the interests of thousands of enterprises and the use of medical institutions.Adjustment variety/Adjustment system may be new essential drugs list need to load problem."Reporters from a little bird place to know,Policy makers have realized the importance of quality guarantee basic drugs,"Only low quoted price"Will have to be adjusted;But to"Whether medical insurance directory and essential drugs list 2 for one"Call did not adopt. Reporter once - thanked interns ginger Korea Beijing